ROZLYTREK (entrectinib) Mechanism of Action | HCP
Prioritizing the Catalytic Gatekeepers through Pan- Inhibitory Mechanism of Entrectinib against ALK, ROS1 and TRKA Tyrosine Kinases | SpringerLink
Entrectinib reverses cytostatic resistance through the inhibition of ABCB1 efflux transporter, but not the CYP3A4 drug-metabolizing enzyme - ScienceDirect
TRK inhibitors block NFKB and induce NRF2 in TRK fusion-positive colon cancer
Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies | Signal Transduction and Targeted Therapy
Frontiers | NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance | Oncology
Profile of entrectinib and its potential in the treatment of ROS1-posi | LCTT
Entrectinib治疗携带NTRK1/2/3、ROS1和ALK基因变异的儿科实体肿瘤，效果确切
Frontiers | NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma | Oncology
Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers - ScienceDirect
JCM | Free Full-Text | The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies | HTML
Therapeutic strategies and mechanisms of drug resistance in anaplastic lymphoma kinase (ALK)-rearranged lung cancer - ScienceDirect
Entrectinib | C31H34F2N6O2 - PubChem
Entrectinib - Wikipedia
Cancers | Free Full-Text | Non-Canonical Thinking for Targeting ALK-Fusion Onco-Proteins in Lung Cancer | HTML
Mechanism of action of entrectinib. Confirmation that the SCYL3-NTRK1... | Download Scientific Diagram
Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer - ScienceDirect
Mechanism of entrectinib in NB. Abbreviation: NB, neuroblastoma. | Download Scientific Diagram
ROZLYTREK (entrectinib) Efficacy | NTRK Fusion+ Solid Tumors
Mechanism of action and in vivo activity of entrectinib in ALK-driven... | Download Scientific Diagram
Frontiers | The Evolving Role of Radiotherapy for Pediatric Cancers With Advancements in Molecular Tumor Characterization and Targeted Therapies | Oncology
